210 related articles for article (PubMed ID: 37031468)
41. Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome.
Ford AC; Harris LA; Lacy BE; Quigley EMM; Moayyedi P
Aliment Pharmacol Ther; 2018 Nov; 48(10):1044-1060. PubMed ID: 30294792
[TBL] [Abstract][Full Text] [Related]
42. Therapist telephone-delivered CBT and web-based CBT compared with treatment as usual in refractory irritable bowel syndrome: the ACTIB three-arm RCT.
Everitt H; Landau S; Little P; Bishop FL; O'Reilly G; Sibelli A; Holland R; Hughes S; Windgassen S; McCrone P; Goldsmith K; Coleman N; Logan R; Chalder T; Moss-Morris R
Health Technol Assess; 2019 Apr; 23(17):1-154. PubMed ID: 31042143
[TBL] [Abstract][Full Text] [Related]
43. Does a diet low in FODMAPs reduce symptoms associated with functional gastrointestinal disorders? A comprehensive systematic review and meta-analysis.
Marsh A; Eslick EM; Eslick GD
Eur J Nutr; 2016 Apr; 55(3):897-906. PubMed ID: 25982757
[TBL] [Abstract][Full Text] [Related]
44. The efficacy and safety of probiotics for patients with constipation-predominant irritable bowel syndrome: A systematic review and meta-analysis based on seventeen randomized controlled trials.
Wen Y; Li J; Long Q; Yue CC; He B; Tang XG
Int J Surg; 2020 Jul; 79():111-119. PubMed ID: 32387213
[TBL] [Abstract][Full Text] [Related]
45. Lactobacillus acidophilus versus placebo in the symptomatic treatment of irritable bowel syndrome: the LAPIBSS randomized trial.
Sadrin S; Sennoune SR; Gout B; Marque S; Moreau J; Grillasca J; Pons O; Maixent JM
Cell Mol Biol (Noisy-le-grand); 2017 Sep; 63(9):122-131. PubMed ID: 28980935
[TBL] [Abstract][Full Text] [Related]
46. Efficacy of probiotic adjuvant therapy for irritable bowel syndrome in children: A systematic review and meta-analysis.
Xu HL; Zou LL; Chen MB; Wang H; Shen WM; Zheng QH; Cui WY
PLoS One; 2021; 16(8):e0255160. PubMed ID: 34358238
[TBL] [Abstract][Full Text] [Related]
47. Bulking agents, antispasmodic and antidepressant medication for the treatment of irritable bowel syndrome.
Quartero AO; Meineche-Schmidt V; Muris J; Rubin G; de Wit N
Cochrane Database Syst Rev; 2005 Apr; (2):CD003460. PubMed ID: 15846668
[TBL] [Abstract][Full Text] [Related]
48. Irritable bowel syndrome symptom severity improves equally with probiotic and placebo.
Lyra A; Hillilä M; Huttunen T; Männikkö S; Taalikka M; Tennilä J; Tarpila A; Lahtinen S; Ouwehand AC; Veijola L
World J Gastroenterol; 2016 Dec; 22(48):10631-10642. PubMed ID: 28082816
[TBL] [Abstract][Full Text] [Related]
49. A randomized placebo-controlled clinical trial of a multi-strain probiotic formulation (Bio-Kult®) in the management of diarrhea-predominant irritable bowel syndrome.
Ishaque SM; Khosruzzaman SM; Ahmed DS; Sah MP
BMC Gastroenterol; 2018 May; 18(1):71. PubMed ID: 29801486
[TBL] [Abstract][Full Text] [Related]
50. [Long-term probiotic administration for irritable bowel syndrome: a legal need].
Solovyeva OI; Nekrasova AS; Topalova IG; Ponomarenko VA; Tsurtsumiia DB; Ilyashevich IG
Ter Arkh; 2023 Oct; 95(8):679-685. PubMed ID: 38158905
[TBL] [Abstract][Full Text] [Related]
51. Strain-specific and outcome-specific efficacy of probiotics for the treatment of irritable bowel syndrome: A systematic review and meta-analysis.
McFarland LV; Karakan T; Karatas A
EClinicalMedicine; 2021 Nov; 41():101154. PubMed ID: 34712929
[TBL] [Abstract][Full Text] [Related]
52. Efficacy and safety profile of LCR35 complete freeze-dried culture in irritable bowel syndrome: a randomized, double-blind study.
Dapoigny M; Piche T; Ducrotte P; Lunaud B; Cardot JM; Bernalier-Donadille A
World J Gastroenterol; 2012 May; 18(17):2067-75. PubMed ID: 22563194
[TBL] [Abstract][Full Text] [Related]
53. Probiotics for treating eczema.
Makrgeorgou A; Leonardi-Bee J; Bath-Hextall FJ; Murrell DF; Tang ML; Roberts A; Boyle RJ
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD006135. PubMed ID: 30480774
[TBL] [Abstract][Full Text] [Related]
54. Meta-analysis of probiotics for the treatment of irritable bowel syndrome.
McFarland LV; Dublin S
World J Gastroenterol; 2008 May; 14(17):2650-61. PubMed ID: 18461650
[TBL] [Abstract][Full Text] [Related]
55. Effects of probiotic supplementation on abdominal pain severity in pediatric patients with irritable bowel syndrome: a systematic review and meta-analysis of randomized clinical trials.
Fatahi S; Hosseini A; Sohouli MH; Sayyari A; Khatami K; Farsani ZF; Amiri H; Dara N; de Souza IGO; Santos HO
World J Pediatr; 2022 May; 18(5):320-332. PubMed ID: 35106700
[TBL] [Abstract][Full Text] [Related]
56. Homeopathy for treatment of irritable bowel syndrome.
Peckham EJ; Nelson EA; Greenhalgh J; Cooper K; Roberts ER; Agrawal A
Cochrane Database Syst Rev; 2013 Nov; (11):CD009710. PubMed ID: 24222383
[TBL] [Abstract][Full Text] [Related]
57. The Efficacy and Safety of Single-Strain Probiotic Formulations Containing
Skrzydło-Radomańska B; Prozorow-Król B; Kurzeja-Mirosław A; Cichoż-Lach H; Laskowska K; Majsiak E; Bierła JB; Agnieszka S; Cukrowska B
J Clin Med; 2023 Jul; 12(14):. PubMed ID: 37510953
[TBL] [Abstract][Full Text] [Related]
58. Effectiveness of osteopathic manipulative therapy for managing symptoms of irritable bowel syndrome: a systematic review.
Müller A; Franke H; Resch KL; Fryer G
J Am Osteopath Assoc; 2014 Jun; 114(6):470-9. PubMed ID: 24917634
[TBL] [Abstract][Full Text] [Related]
59. Efficacy and safety of Bacillus coagulans LBSC in irritable bowel syndrome: A prospective, interventional, randomized, double-blind, placebo-controlled clinical study [CONSORT Compliant].
Gupta AK; Maity C
Medicine (Baltimore); 2021 Jan; 100(3):e23641. PubMed ID: 33545934
[TBL] [Abstract][Full Text] [Related]
60. Prebiotics in irritable bowel syndrome and other functional bowel disorders in adults: a systematic review and meta-analysis of randomized controlled trials.
Wilson B; Rossi M; Dimidi E; Whelan K
Am J Clin Nutr; 2019 Apr; 109(4):1098-1111. PubMed ID: 30949662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
